Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/17/2025
CDE Solicits Comments on Draft Guidance for mRNA Vaccine Research
9/13/2025
China to Incorporate HPV Vaccines into National Immunization Program
9/9/2025
RemeGen's Telitacicept Advances in Sjögren's Syndrome
9/8/2025
NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...
9/3/2025
Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
9/3/2025
Aon Report Highlights Rapid Growth and Challenges in China's Health In...
8/26/2025
Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...
8/22/2025
NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children
8/21/2025
Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets
8/21/2025
Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...
8/20/2025
Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...
8/20/2025
On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...
8/14/2025
Remegen's Telitacicept Achieves Phase III Success
8/12/2025
Akeso Doses First Patient in Phase III Trial of Ivonescimab
8/8/2025
Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...
8/8/2025
Boan's Dulaglutide Biosimilar Secures NMPA Approval in China
8/6/2025
MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
8/5/2025
China Seeks Public Feedback on New Internet Drug and Device Informatio...
8/5/2025
Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...
8/5/2025
MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
7/31/2025
China's Plan to Boost Drug Coverage by Commercial Insurers No 'Magic W...
7/29/2025
Merck Faces China Headwinds as Gardasil Pause Drags on Q2 Results
7/29/2025
Pfizer Launches Landmark Pneumococcal Vaccine Trial in China, Pioneeri...
7/26/2025
China's Sciwind in Licensing Talks to Bring Weight-Loss Drug to U.S. M...
7/25/2025
Newish Secures Series B1 Investment to Propel Nucleic Acid Cancer Vac...
7/23/2025
China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals
7/22/2025
Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines
7/18/2025
SKBio Wins Chinese Clinical Trial Approval for GBP410
7/12/2025
China's First 9-Valent HPV Vaccine Launches at 60% Discount, Undercutt...
7/11/2025
Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
Page:
1
/
74
Total number of articles:
2197
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit